Intelligence Unit
Special Reports
Special Events
Subscribe
Sponsored
Departments
- Leadership
- Finance
- Technology
- Physicians
- Community Hospitals
- Health Plans
- Marketing
- Quality
- Nursing
- HR
Follow Us
Medicare overspending on anemia drug
Washington Post, August 10, 2012
The U.S. health-care system is vastly overspending for a single anemia drug because Medicare overestimates its use by hundreds of millions of dollars a year, according to an analysis of federal data. The overpayment to hospitals and clinics arises because Medicare reimburses them based on estimates rather than the actual use of the drug.
Most Viewed
Most Emailed
- Building a Better Healthcare Board
- 69% of Employers Plan to Offer Healthcare Coverage After 2014
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Hospital Pricing Data Dump Won't Hurt You, Yet
- Case Study: Advance Care Conversations
- Primary Care Docs Average More Hospital Revenue Than Specialists
- Quiet ORs Better for Patient Safety
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- CMS Releases Hospital Pricing Data
- Hard-Nosed About Physician Teamwork
